logo

For the Inventor, By the Inventor

West Orange, NJ, United States of America

Charles R Spillert

USPTO Granted Patents = 14

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 187(Granted Patents)


Company Filing History:

goldMedal13 out of 272 
 
University of Medicine and Dentistry of New Jersey
 patents
silverMedal1 out of 832,912 
Other
 patents

Years Active: 1986-2013

Loading Chart...
14 patents (USPTO):Explore Patents
1. 8530455 - Hemostatic effects of glucono-delta-lactone (2013-09-10),
2. 7094428 - Hemostatic compositions, devices and methods (2006-08-22),
3. 6514766 - Modified erythrocyte sedimentation rate (2003-02-04),
4. 6245573 - Rapid assessment of the coagulant activity of blood (2001-06-12),
5. 5792660 - Comparative determinants of viscosity in body fluids obtained with (1998-08-11),
6. 5783447 - Hypercoagulability comparative determinants obtained using detection (1998-07-21),
7. 4900679 - Method for determining the existence and/or the monitoring of a (1990-02-13),
8. 4833132 - Process for treating a warm-blooded animal with an (1989-05-23),
9. 4814247 - Method for determining the existance and/or the monitoring of a (1989-03-21),
10. 4705756 - Method of determining the existence and/or the monitoring of a (1987-11-10),
11. 4698335 - Process for treating a warm-blooded animal to be subjected to (1987-10-06),
12. 4661478 - Process for potentiating effects of barbituate anesthesia to a (1987-04-28),
13. 4632920 - Process for treating a warm-blooded animal following burn injury (1986-12-30),
14. 4632919 - Process for prolonging recalcification, prothrombin and thrombin times (1986-12-30),

Title: Innovations by Charles R Spillert

Introduction

Charles R Spillert is a notable inventor based in West Orange, NJ (US), recognized for his contributions to the field of medical technology. He holds a total of 14 patents, showcasing his innovative spirit and dedication to advancing healthcare solutions.

Latest Patents

Among his latest patents is the invention related to the hemostatic effects of glucono-delta-lactone. This compound can mediate the human blood coagulation process, serving as a valuable tool in assessing an individual's risk for accelerated blood clotting. Additionally, it can be utilized as a treatment for conditions associated with accelerated clotting potential and inflammatory states. Another significant patent involves hemostatic compositions, devices, and methods. This invention includes a hemostatic composition that comprises at least one procoagulant metal ion and at least one procoagulant biopolymer. The composition can be formulated in various forms, such as paste, dough, glue, liquid, lyophilized powder, or foam, for application to wounds. The associated hemostatic device can take the form of a plug, bandage, gauze, cloth, tampon, membrane, or sponge, providing effective solutions for bleeding management.

Career Highlights

Throughout his career, Charles has worked with esteemed institutions, including the University of Medicine and Dentistry of New Jersey. His work has significantly impacted the medical field, particularly in developing innovative hemostatic solutions.

Collaborations

Charles has collaborated with notable individuals such as Eric J Lazaro and Corinne Devereux, contributing to the advancement of his inventions and research.

Conclusion

Charles R Spillert's innovative contributions to medical technology, particularly in hemostatic solutions, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving healthcare outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…